Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  NuPathe Inc    PATH   US67059M1009

NUPATHE INC (PATH)

3
 SummaryQuotesNewsCalendarCompanyFinancials 
Company
NuPathe Inc. is a biopharmaceutical company focused on the development and commercialization of branded therapeutics for diseases of the central nervous system, including neurological and psychiatric disorders.Its primary product, Zecuity (sumatriptan iontophoretic transdermal) for the acute... 
Sector
Pharmaceuticals
Calendar
08/11Earnings Release
More about the company
Latest news on NUPATHE INC
05/01DJDrug Maker Mylan Sues Law Firm Kirkland & Ellis
2014 Analysis - Replay of energetic deal-making seen for drugmakers in 2014
2014DJU.S. HOT STOCKS : Hot Stocks to Watch
2014 NUPATHE INC : Endo Merger Agreement with NuPathe Terminated
2014 NuPathe Terminates Agreement With Endo and Enters Into Agreement to Be Acquir..
2014 NUPATHE INC : NuPathe Inc. Stockholders Encouraged to Contact Securities Law Fir..
2014 S&P 500 ends flat in wake of Fed minutes
2014DJU.S. HOT STOCKS : Hot Stocks to Watch
More news
Sector news : Pharmaceuticals - NEC
07:35p TAKEDA PHARMACEUTICAL : ZAFATEK® Now Available for the Treatment of Type 2 Diabe..
05:59p VALEANT PHARMACEUTICALS INTL : Salix Announces FDA Approval of Xifaxan® 550 mg f..
05:59p VALEANT PHARMACEUTICALS INTL : Salix Announces FDA Approval of Xifaxan® 550 mg f..
More sector news : Pharmaceuticals - NEC


Comments 
Advertisement
Income Statement Evolution
More Financials